PRESENTATIONS
Corporate Presentation
September 2021
Barclays Global Healthcare Conference
2021 Presentation
Jefferies Virtual Healthcare Conference
2021 Presentation
Investor Relations
Should you wish to subscribe to emails and updates, click here.
To contact Investor Relations, please click here.
JANUARY 2022 EXTRAORDINARY GENERAL MEETING
Proxy
PAST EVENTS
Copy
Copy
Copy
CORPORATE GOVERNANCE
At RVL Pharmaceuticals, we are committed to maintaining the highest standards of business conduct and ethics every day. Our approach to corporate compliance reflects the business practices and principles of behavior that support this commitment, and we expect every employee, officer, and director to honor this commitment in the performance of his or her business responsibilities. It is the responsibility of each employee to abide by the law as well as the ethical standards set forth in our Code of Business Conduct and Ethics, which can be accessed here.
RVL Pharmaceuticals is committed to establishing and maintaining an effective compliance program in accordance with “Compliance Program Guidance for Pharmaceutical Manufacturers,” published by the Office of Inspector General, U.S. Department of Health and Human Services (the “HHS-OIG Guidance”). Our Compliance Program is one of the key components of our commitment to the highest standards of corporate conduct. Click here for more information about our Compliance Program.
Part of our commitment to integrity and ethical business practices includes our obligation to report violations of our Code, other policies, and the law. To report a concern, please visit our Compliance and Ethics Hotline Portal here.
SEC FILINGS
FREQUENTLY ASKED QUESTIONS
On what stock exchange are RVL Pharmaceuticals shares traded, and what is the ticker symbol?
RVL Pharmaceuticals is listed on the NASDAQ Global Market and traded under the ticker symbol [to come].
Where can I find RVL Pharmaceuticals’ current and historic share price?
Please refer to the Stock Information section of the website, which allows you to look at both current and historic share price data.
How can I purchase RVL Pharmaceuticals’ common stock?
RVL Pharmaceuticals’ common stock may be purchased through a registered broker on the open market.
Where can I find all of RVL Pharmaceuticals’ regulatory filings, including quarterly and annual reports?
Quarterly and annual reports, as well as other regulatory filings, can be accessed on the SEC Filings section of our website or on the SEC’s website: www.sec.gov.
When does RVL Pharmaceuticals’ fiscal year end?
Our fiscal year ends December 31.
Does RVL Pharmaceuticals pay cash dividends?
We do not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.
Who are the company’s independent registered public accountants?
Ernst & Young.
Who is the company’s transfer agent?
Our transfer agent is Computershare. They can be reached at:
Computershare Investor Services
Computershare
P.O. Box 505000
Louisville, KY 40233-5000
1-877-373-6374 (US, Canada, Puerto Rico)
1-781-575-3100 (non-US)
www.computershare.com/investor
By overnight delivery:
Computershare
462 South 4th Street, Suite 1600
Louisville, KY 40202
Email: web.queries@computershare.com
Shareholder Online Inquiries: https://www-us.computershare.com/investor/Contact
How do I contact Investor Relations with a question or request?
You can contact RVL Pharmaceuticals Investor Relations via email at: IR@RVLPharma.com. In addition, you can reach Investor Relations by calling 212-452-2793.
Where is RVL Pharmaceuticals’ US corporate headquarters?
RVL Pharmaceuticals is headquartered in Bridgewater, NJ.
How can I be added to RVL Pharmaceuticals’ mailing list?
You can sign up for e-mail alerts notifying you of press releases, SEC filings, or corporate news and events by clicking here.